NASDAQ:CPTS - Bayer Essure Stock Price, Forecast & News

Add

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Conceptus, Inc designs, develops, markets and promotes solutions in women's healthcare. The Company's flagship product is the Essure permanent birth control procedure, which is the non-surgical permanent birth control system. The Essure delivers a soft and flexible insert into a woman's fallopian tubes, causing a benign tissue in-growth, which blocks the fallopian tubes. Read More…

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry N/A

Sub-IndustryHealth Care Equipment

SectorN/A

Current SymbolNASDAQ:CPTS

Previous Symbol

CUSIP20601610

CIK896778

Webhttp://www.conceptus.com/

Phone+1-302-6365400

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

EmployeesN/A

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

Receive CPTS News and Ratings via Email

Sign-up to receive the latest news and ratings for CPTS and its competitors with MarketBeat's FREE daily newsletter.

Bayer Essure (NASDAQ:CPTS) Frequently Asked Questions

What is Bayer Essure's stock symbol?

Bayer Essure trades on the NASDAQ under the ticker symbol "CPTS."

Has Bayer Essure been receiving favorable news coverage?

Media headlines about CPTS stock have been trending somewhat negative this week, according to InfoTrie. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Bayer Essure earned a media sentiment score of -1.1 on InfoTrie's scale. They also assigned press coverage about the healthcare company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Bayer Essure.

Who are some of Bayer Essure's key competitors?

Some companies that are related to Bayer Essure include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Steris (STE) and Varian Medical Systems (VAR).

How do I buy shares of Bayer Essure?

Shares of CPTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Bayer Essure's official website?

The official website for Bayer Essure is http://www.conceptus.com/.

How can I contact Bayer Essure?

Bayer Essure's mailing address is 100 Bayer Rd, PITTSBURGH, PA 15205-9707, United States. The healthcare company can be reached via phone at +1-302-6365400.

MarketBeat Community Rating for Bayer Essure (NASDAQ CPTS)

Community Ranking:		2.8 out of 5 ( )
Outperform Votes:		117 (Vote Outperform)
Underperform Votes:		94 (Vote Underperform)
Total Votes:		211

MarketBeat's community ratings are surveys of what our community members think about Bayer Essure and other stocks. Vote "Outperform" if you believe CPTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CPTS will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 12/11/2019 by MarketBeat.com Staff

Featured Article: What are benefits of a growth and income fund?